Cooper, David A <br/><br/>
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.  [electronic resource] 

 -  AIDS (London, England)  Mar 2014 
 - 717-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0000000000000131  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Alkynes<br/>Anti-HIV Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>Benzoxazines--adverse effects<br/>CD4 Lymphocyte Count<br/>Cyclohexanes--adverse effects<br/>Cyclopropanes<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--isolation & purification<br/>Humans<br/>Male<br/>Maraviroc<br/>Middle Aged<br/>Treatment Outcome<br/>Triazoles--adverse effects<br/>Viral Load<br/>Young Adult